Prime named 2021 Minnesota Women Lawyers Leadership Award recipient

Support for women in the workplace celebrated

April 30, 2021
Minnesota Women Lawyers (MWL) presented Prime Therapeutics with the MWL Leadership Award at its recent 49th Annual Meeting. This annual award recognizes a Minnesota legal employer that strives to enhance the status, influence and effectiveness of women lawyers.

Prime is committed to advancing the success of women in the legal department in a variety of ways:

  • Prime’s legal leadership team of five includes three women, all of whom have been promoted multiple times during their employment with Prime, and two of whom are company officers and members of Prime’s senior leadership team
  • Three of the nine lawyers in the legal department are women and nine of the 18 employees in the department are women
  • Effective Jan. 1, 2021, Prime’s legal department implemented a policy intended to hold its law firm vendors directly accountable to Prime for their efforts toward driving greater diversity, equity and inclusion among the attorneys who represent Prime

The MWL Leadership Award recognition is an extension of Prime’s overall commitment to women throughout its organization. Prime recruits and hires women at all levels of the company and participated in outreach efforts that increased female candidates by nearly 20% from 2019 to 2020.

“The legal profession is the nation’s least diverse profession, so developing and supporting women lawyers as leaders, both within Prime and the legal profession, is work that legal employers must continue to focus on,” says Amy Taber, AVP, assistant general counsel. “I’m grateful to work for a company that is recognized for its leadership in supporting women lawyers and to have Mike Kolar as a General Counsel who is committed to this work.”

Related news


May 15, 2024

Prime/MRx experts share clinical insights for migraine treatment

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs


May 14, 2024

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended


May 14, 2024

Prime/MRx releases its first corporate social responsibility report

New report, an evolution of previous DEI reports, aims to demonstrate transparency and accountability for company’s corporate social responsibility journey